Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 96.0 % |
Melting Point | 226-229°C |
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride
4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C19H27N5O4·HCl = 425.91 |
Physical State (20 deg.C) | Solid |
CAS RN | 81403-68-1 |
Unit | Price |
100 mg | 4950 |
500 mg | 7950 |
1 g | 11975 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 96.0 % |
Melting Point | 226-229°C |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|